News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Vital Images, Inc. Announces Fourth Quarter and Full-Year Results and 2008 Guidance
February 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MINNEAPOLIS, MN--(Marketwire - February 21, 2008) - Vital Images, Inc. (NASDAQ: VTAL) -- Fourth quarter revenue of $16.7 million, compared to $20.0 million in the fourth quarter of 2006;
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues
October 29, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
J&J, Lilly Crest AI Wave With Nvidia Partnerships
October 29, 2025
·
2 min read
·
Tristan Manalac
Podcast
Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More
October 29, 2025
·
1 min read
·
Heather McKenzie
Earnings
Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem
October 28, 2025
·
3 min read
·
Annalee Armstrong